Labeling of cytoplasmic liver RNA by (6- 14 C)orotic and 5-fluoro(2- 14 C)orotic acids. Effect of several inhibitors.
D000818:Animals; D001372:Aza Compounds / Q000494:pharmacology; D001374:Azacitidine / Q000494:pharmacology; D002247:Carbon Isotopes; D002474:Cell-Free System; D002499:Centrifugation, Density Gradient; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D002854:Chromatography, Paper; D003593:Cytoplasm / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D005461:Fluorine; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009963:Orotic Acid / Q000378:metabolism* / Q000494:pharmacology; D011132:Polyribosomes / Q000032:analysis; D012313:RNA / Q000032:analysis / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000096:biosynthesis; D012335:RNA, Ribosomal / Q000096:biosynthesis; D051381:Rats; D013997:Time Factors
D001372:Aza Compounds; D002247:Carbon Isotopes; D012333:RNA, Messenger; D012335:RNA, Ribosomal; D003609:Dactinomycin; D005461:Fluorine; D009963:Orotic Acid; D012313:RNA; D001374:Azacitidine